Study of the Pharmacokinetics, Safety, and Tolerability of ZONISADE in Children 1 Month to 17 Years of Age With Partial-onset Seizures

Clinical trial NCT06534502 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06534502
Sponsor: Azurity Pharmaceuticals
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Seizures Seizures, Focal Seizure, Partial Onset Seizure Disorder, Partial Seizure, Partial Epilepsies, Partial Epilepsy

Start date: 2026-09-01
Primary completion: 2027-09-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.